Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.

Babayeva M, Assefa H, Basu P, Chumki S, Loewy Z.

Parkinsons Dis. 2016;2016:1279042. doi: 10.1155/2016/1279042. Epub 2016 Dec 5. Review.

2.
3.

The mediating roles of coping, sleep, and anxiety motives in cannabis use and problems among returning veterans with PTSD and MDD.

Metrik J, Jackson K, Bassett SS, Zvolensky MJ, Seal K, Borsari B.

Psychol Addict Behav. 2016 Nov;30(7):743-754. Epub 2016 Oct 27.

PMID:
27786514
4.

Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.

Murray RM, Quigley H, Quattrone D, Englund A, Di Forti M.

World Psychiatry. 2016 Oct;15(3):195-204. doi: 10.1002/wps.20341.

5.

The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism.

Jenny M, Schröcksnadel S, Überall F, Fuchs D.

Pharmaceuticals (Basel). 2010 Aug 13;3(8):2647-2660. Review.

6.

Cannabis and development of dual diagnoses: A literature review.

Hanna RC, Perez JM, Ghose S.

Am J Drug Alcohol Abuse. 2016 Sep 9:1-14. [Epub ahead of print]

PMID:
27612527
7.

Testing Longitudinal Relationships Between Binge Drinking, Marijuana Use, and Depressive Symptoms and Moderation by Sex.

Wilkinson AL, Halpern CT, Herring AH, Shanahan M, Ennett ST, Hussey JM, Harris KM.

J Adolesc Health. 2016 Dec;59(6):681-687. doi: 10.1016/j.jadohealth.2016.07.010. Epub 2016 Aug 25.

PMID:
27567065
8.

Association between cannabis use and treatment outcomes in patients receiving methadone maintenance treatment: a systematic review protocol.

Zielinski L, Bhatt M, Eisen RB, Perera S, Bhatnagar N, MacKillop J, Steiner M, McDermid Vaz S, Thabane L, Samaan Z.

Syst Rev. 2016 Aug 16;5(1):139. doi: 10.1186/s13643-016-0317-2.

9.

The genetic basis of the comorbidity between cannabis use and major depression.

Hodgson K, Almasy L, Knowles EE, Kent JW Jr, Curran JE, Dyer TD, Göring HH, Olvera RL, Woolsey MD, Duggirala R, Fox PT, Blangero J, Glahn DC.

Addiction. 2017 Jan;112(1):113-123. doi: 10.1111/add.13558. Epub 2016 Sep 26.

PMID:
27517884
10.

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review.

Copeland J, Pokorski I.

Subst Abuse Rehabil. 2016 May 3;7:41-53. doi: 10.2147/SAR.S89857. eCollection 2016 May 3. Review.

11.

Gender Differences in Internalizing Symptoms and Suicide Risk Among Men and Women Seeking Treatment for Cannabis Use Disorder from Late Adolescence to Middle Adulthood.

Foster KT, Li N, McClure EA, Sonne SC, Gray KM.

J Subst Abuse Treat. 2016 Jul;66:16-22. doi: 10.1016/j.jsat.2016.01.012. Epub 2016 Feb 13.

PMID:
27211992
12.

Use of novel psychoactive substances by inpatients on general adult psychiatric wards.

Stanley JL, Mogford DV, Lawrence RJ, Lawrie SM.

BMJ Open. 2016 May 10;6(5):e009430. doi: 10.1136/bmjopen-2015-009430.

13.

Substance Use and Depressive Symptoms among Adolescents Treated in a Pediatric Emergency Department.

Hernandez L, Cancilliere MK, Graves H, Chun TH, Lewander W, Spirito A.

J Child Adolesc Subst Abuse. 2016 Mar 1;25(2):124-133. Epub 2015 Dec 14.

14.

Screening Medications for the Treatment of Cannabis Use Disorder.

Panlilio LV, Justinova Z, Trigo JM, Le Foll B.

Int Rev Neurobiol. 2016;126:87-120. doi: 10.1016/bs.irn.2016.02.005. Epub 2016 Mar 10. Review.

15.
16.

Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study.

Mokrysz C, Landy R, Gage SH, Munafò MR, Roiser JP, Curran HV.

J Psychopharmacol. 2016 Feb;30(2):159-68. doi: 10.1177/0269881115622241. Epub 2016 Jan 6.

17.

The Use of Medicinal Marijuana for Posttraumatic Stress Disorder: A Review of the Current Literature.

Yarnell S.

Prim Care Companion CNS Disord. 2015 May 7;17(3). doi: 10.4088/PCC.15r01786. eCollection 2015 May 7.

18.

The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy.

Zhang MW, Ho RC.

J Addict. 2015;2015:707596. doi: 10.1155/2015/707596. Epub 2015 Oct 11. Review.

19.

Can marijuana make it better? Prospective effects of marijuana and temperament on risk for anxiety and depression.

Grunberg VA, Cordova KA, Bidwell LC, Ito TA.

Psychol Addict Behav. 2015 Sep;29(3):590-602. doi: 10.1037/adb0000109.

20.

Associations of adolescent cannabis use with academic performance and mental health: A longitudinal study of upper middle class youth.

Meier MH, Hill ML, Small PJ, Luthar SS.

Drug Alcohol Depend. 2015 Nov 1;156:207-12. doi: 10.1016/j.drugalcdep.2015.09.010. Epub 2015 Sep 21.

Supplemental Content

Support Center